索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]范骎,陶蓉.亲环素A在动脉粥样硬化中的作用[J].国际心血管病杂志,2015,06:399-402.
点击复制

亲环素A在动脉粥样硬化中的作用(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2015年06期
页码:
399-402
栏目:
综述
出版日期:
2015-11-25

文章信息/Info

Title:
-
作者:
范骎; 陶蓉
200025 上海交通大学医学院附属瑞金医院心脏科
Author(s):
-
关键词:
亲环素A; 细胞外基质金属蛋白酶诱导因子; 动脉粥样硬化; 炎症
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2015.06.009
文献标识码:
-
摘要:
亲环素A(cyclophilinA,CyPA)是血管平滑肌细胞和巨噬细胞在受到活性氧簇的刺激后分泌的一种蛋白质。研究表明,CyPA直接参与血管的氧化与炎症反应,介导炎症细胞的迁移及血管平滑肌细胞的增生,并且在动脉粥样硬化斑块的产生与破裂过程中发挥重要作用。该文就CyPA在动脉粥样硬化中的作用及其机制作一介绍。
Abstract:
-

参考文献/References

[1] Seizer P, Gawaz M, May AE. Cyclophilin A and EMMPRIN(CD147)in cardiovascular diseases [J]. Cardiovasc Res, 2014, 102(1): 17-23.
[2] Handschumacher RE, Harding MW, Rice J, et al. Cyclophilin: a specific cytosolic binding protein for cyclosporin A [J]. Science, 1984, 226(4674): 544-547.
[3] Ramachandran S, Venugopal A, Sathisha K, et al. Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes [J]. Proteomics, 2012, 12(18): 2808-2821.
[4] Seizer P, Schönberger T, Schött M, et al. EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation [J]. Atherosclerosis, 2010, 209(1): 51-57.
[5] Jin ZG, Melaragno MG, Liao DF, et al. Cyclophilin A is a secreted growth factor induced by oxidative stress [J]. Circ Res, 2000, 87(9): 789-796.
[6] Suzuki J, Jin ZG, Meoli DF, et al. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells [J]. Circ Res, 2006, 98(6): 811-817.
[7] Ramachandran S, Kartha CC. Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes [J]. Can J Physiol Pharmacol, 2012, 90(8): 1005-1015.
[8] Jin ZG, Lungu AO, Xie L, et al. Cyclophilin A is a proinflammatory cytokine that activates endothelial cells [J]. Arterioscler Thromb Vasc Biol, 2004, 24(7): 1186-1191.
[9] Satoh K, Matoba T, Suzuki J, et al. Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation [J]. Circulation, 2008, 117(24): 3088-3098.
[10] Nigro P, Satoh K, O'Dell MR, et al. Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice [J]. J Exp Med, 2011, 208(1): 53-66.
[11] Song F, Zhang X, Ren XB, et al. CyclophilinA(CyPA)induces chemotaxis independent of its peptidylprolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CD147 [J]. J Biol Chem, 2011, 286(10): 8197-8203.
[12] Damsker JM, Bukrinsky MI, Constant SL. Preferential chemotaxis of activated human CD4+T cells by extracellular cyclophilin A [J]. J Leukoc Biol, 2007, 82(3): 613-618.
[13] Soe NN, Sowden M, Baskaran P, et al. Acetylation of cyclophilin A is required for its secretion and vascular cell activation [J]. Cardiovasc Res, 2014, 101(3): 444-453.
[14] Schmidt R, Bültmann A, Fischel S, et al. Extracellular cyclophilin-A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B [J]. Circ Res, 2008, 102(3): 302-309.
[15] Rezzani R, Favero G, Stacchiotti A, et al. Endothelial and vascular smooth muscle cell dysfunction mediated by cyclophylin A and the atheroprotective effects of melatonin [J]. Life Sci, 2013, 92(17-19): 875-882.
[16] Shimokawa H. Reactive oxygen species promote vascular smooth muscle cell proliferation [J]. Circ Res, 2013, 113(9): 1040-1042.
[17] Satoh K, Godo S, Saito H, et al. Dual roles of vascular-derived reactive oxygen species—with a special reference to hydrogen peroxide and cyclophilin A [J]. J Mol Cell Cardiol, 2014, 73: 50-56.
[18] 熊普熹, 刘晓红, 韩 林. 活性氧参与心血管钙化发病机制的研究进展 [J]. 国际心血管病杂志, 2014, 41(5): 291-293.
[19] 石 健, 侯静波. 基质金属蛋白酶与动脉粥样硬化关系研究新进展 [J]. 国际心血管病杂志, 2013, 40(1): 25-27.
[20] Newby AC. Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation [J]. Matrix Biol, 2015, 44-46: 157-166.
[21] Satoh K, Fukumoto Y, Sugimura K, et al. Plasma cyclophilin A is a novel biomarker for coronary artery disease [J]. Circ J, 2013, 77(2): 447-455.
[22] Yin X, Subramanian S, Hwang SJ, et al. Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative [J]. Arterioscler Thromb Vasc Biol, 2014, 34(4): 939-945.
[23] Satoh K, Shimokawa H, Berk BC. Cyclophilin A: promising new target in cardiovascular therapy [J]. Circ J, 2010, 74(11): 2249-2256.
[24] Seizer P, Klingel K, Sauter M, et al. Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis [J]. J Mol Cell Cardiol, 2012, 53(1): 6-14.

备注/Memo

备注/Memo:
通信作者:陶 蓉,Email:rongtao@hotmail.com
更新日期/Last Update: 2015-12-20